Digital Content 
NEWS #PharmaBuzz
17 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250317475458/en/Xeris-Announces-Approval-of-Supplemental-New-Drug-Application-sNDA-of-Gvoke-VialDx-glucagon-for-Use-as-a-Diagnostic-Aid
17 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/17/3043648/0/en/OPKO-Health-and-Entera-Bio-Enter-into-Collaboration-Agreement-to-Advance-Oral-GLP-1-Glucagon-Tablet-Candidate-into-the-Clinic-to-Treat-Obesity-and-Metabolic-Disorders.html
12 Dec 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204468
10 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/10/2943735/0/en/Abvance-Therapeutics-Announces-3-9M-Program-Related-Investment-from-the-Helmsley-Charitable-Trust-to-Support-Development-of-Its-Novel-Insulin-and-Glucagon-Combined-Formulation.html
29 Jul 2024
// ACCESSWIRE
25 Apr 2023
// REUTERS
https://www.reuters.com/markets/deals/eli-lilly-sell-low-blood-sugar-drug-amphastar-2023-04-24/
Share 